Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina Tbk (ISX:HEAL) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
PT Medikaloka Hermina Tbk Forward PE Ratio Related Terms
PT Medikaloka Hermina Tbk Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk Forward PE Ratio Chart
PT Medikaloka Hermina Tbk Annual Data
Trend
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
36.76
40.49
26.88
23.87
49.26
32.57
33.08
33.08
PT Medikaloka Hermina Tbk Quarterly Data
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
36.76
52.08
60.61
38.61
40.49
22.68
37.74
32.68
26.88
33.44
34.25
23.70
23.87
28.49
33.67
51.02
49.26
24.45
30.96
23.36
32.57
28.01
28.74
28.41
33.08
23.61
35.14
36.49
33.08
30.61
26.93
ISX:HEAL vs HCA, THC, EHC: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Forward PE Ratio falls into.
PT Medikaloka Hermina Tbk Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Forward PE Ratio of 16.90 as of Sep. 17, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PT Medikaloka Hermina Tbk and its competitors. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #162 out of 319 companies in the Healthcare Providers & Services industry, placing it in the top 50.8%.
Is PT Medikaloka Hermina Tbk's Forward PE Ratio too high?
PT Medikaloka Hermina Tbk's current Forward PE Ratio is 16.90. The Healthcare Providers & Services industry median Forward PE Ratio is 16.75. PT Medikaloka Hermina Tbk's value of 16.90 is 0.9% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #162 out of 319 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #162 out of 319 companies for Forward PE Ratio. This places PT Medikaloka Hermina Tbk in the lower half of its industry. The industry median Forward PE Ratio is 16.75. PT Medikaloka Hermina Tbk's value of 16.90 is 0.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 16.75, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Forward PE Ratio of 16.90 is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 16.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Forward PE Ratio is 16.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,575.12, compared to a current price of Rp680.00 — trading 56.8% below its estimated fair value. The current Forward PE Ratio is 16.90 and 0.9% above the Healthcare Providers & Services industry median of 16.75. PT Medikaloka Hermina Tbk's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Forward PE Ratio is 16.90 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp680.00 is trading 56.8% below its estimated GF Value™ of Rp1,575.12.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Forward PE Ratio: 16.90
GF Value™: Rp1,575.12 vs. price of Rp680.00 (56.8% below fair value)
Industry Position: 0.9% above the Healthcare Providers & Services median (#162 of 319)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
66GF Score
Get the complete analysis for ISX:HEAL
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
